
  
    
      
        Background_NNP
        With_IN the_DT rising_VBG trend_NN towards_IN consumerism_NN in_IN health_NN ,_,
        patients_NNS are_VBP increasingly_RB encouraged_VBN to_TO become_VB involved_VBN in_IN
        making_VBG decisions_NNS about_IN their_PRP$ health_NN ._. Marketing_NN campaigns_NNS
        for_IN prescription_NN drugs_NNS are_VBP now_RB being_VBG directed_VBN towards_IN
        patients_NNS ,_, with_IN advertisements_NNS appearing_VBG in_IN the_DT popular_JJ
        press_NN suggesting_VBG that_IN patients_NNS discuss_VBP medications_NNS and_CC
        treatment_NN options_NNS with_IN their_PRP$ doctors_NNS ._. A_DT recent_JJ study_NN
        examining_VBG the_DT effect_NN of_IN drug_NN advertisements_NNS on_IN consumer_NN
        behavior_NN found_VBD that_IN 19_CD %_NN of_IN study_NN participants_NNS asked_VBD for_IN a_DT
        prescription_NN ,_, and_CC 35_CD %_NN asked_VBD a_DT physician_NN for_IN information_NN
        about_IN a_DT drug_NN after_IN seeing_VBG a_DT drug_NN advertisement_NN [_NN 1_CD ]_NN ._. In_IN
        order_NN for_IN patients_NNS to_TO be_VB effective_JJ participants_NNS in_IN the_DT
        decision_NN making_VBG process_NN ,_, they_PRP need_VBP information_NN on_IN the_DT
        effects_NNS of_IN treatment_NN on_IN their_PRP$ health_NN risks_NNS that_IN they_PRP can_MD
        use_VB to_TO make_VB health_NN care_NN decisions_NNS ._. The_DT challenge_NN to_TO
        clinicians_NNS is_VBZ how_WRB to_TO present_VB risk_NN information_NN to_TO patients_NNS
        that_IN they_PRP can_MD use_VB in_IN a_DT format_NN that_IN they_PRP prefer_VBP ._.
        Several_JJ studies_NNS have_VBP examined_VBN how_WRB presentation_NN ,_, [_NN 2_CD 3_CD 4_CD
        ]_NN wording_NN ,_, [_NN 5_CD ]_NN and_CC framing_VBG [_NN 6_CD 7_CD ]_NN affect_NN physicians_NNS '_POS
        interpretations_NNS of_IN numeric_JJ data_NNS as_RB well_RB as_IN their_PRP$
        willingness_NN to_TO initiate_VB treatment_NN [_NN 8_CD ]_NN ._. However_RB ,_, few_JJ
        studies_NNS have_VBP examined_VBN the_DT effect_NN on_IN patients_NNS of_IN framing_VBG
        risk_NN data_NNS with_IN different_JJ metrics_NNS ,_, such_JJ as_IN relative_JJ or_CC
        absolute_JJ risk_NN and_CC the_DT number_NN needed_VBN to_TO treat_VB (_( NNT_NNP )_) ._.
        Relative_NNP risk_NN describes_VBZ the_DT ratio_NN of_IN the_DT risk_NN of_IN disease_NN in_IN
        one_CD group_NN compared_VBN to_TO that_DT in_IN another_DT and_CC does_VBZ not_RB take_VB
        into_IN consideration_NN a_DT person_NN 's_POS baseline_NN risk_NN ._. Absolute_JJ risk_NN
        describes_VBZ the_DT difference_NN between_IN the_DT risks_NNS of_IN disease_NN in_IN
        two_CD populations_NNS and_CC varies_VBZ according_VBG to_TO baseline_NN risk_NN ._. A_DT
        derivative_NN of_IN absolute_JJ risk_NN is_VBZ the_DT NNT_NNP with_IN a_DT specific_JJ
        therapy_NN to_TO prevent_VB one_CD adverse_JJ outcome_NN (_( the_DT inverse_NN of_IN the_DT
        difference_NN in_IN absolute_JJ risk_NN )_) ._. Framing_NNP the_DT benefits_NNS of_IN
        treatment_NN in_IN relative_JJ rather_RB than_IN absolute_JJ terms_NNS may_MD
        emphasize_VB the_DT short-term_JJ benefits_NNS of_IN a_DT treatment_NN [_NN 6_CD 9_CD ]_NN ._.
        Conversely_RB ,_, framing_VBG the_DT risks_NNS of_IN treatment_NN in_IN relative_JJ
        rather_RB than_IN absolute_JJ terms_NNS may_MD emphasize_VB its_PRP$ risks_NNS [_NN 10_CD ]_NN ._.
        Comparing_VBG relative_JJ and_CC absolute_JJ risk_NN reduction_NN and_CC NNT_NNP as_IN
        methods_NNS to_TO inform_VB patients_NNS about_IN preventive_JJ therapies_NNS ,_, Hux_NNP
        et_CC al_NN illustrated_VBN that_IN the_DT metric_JJ used_VBN to_TO present_JJ data_NNS can_MD
        affect_VB a_DT patient_NN 's_POS perception_NN of_IN a_DT therapy_NN 's_POS effectiveness_NN
        [_NN 11_CD ]_NN ._.
        In_IN addition_NN to_TO consideration_NN of_IN which_WDT metric_NN is_VBZ used_VBN to_TO
        describe_VB risks_NNS ,_, the_DT time_NN horizon_NN over_IN which_WDT risks_NNS or_CC
        benefits_NNS occur_VBP may_MD affect_VB risk_NN interpretation_NN ._. Typically_RB ,_,
        risks_NNS framed_VBN in_IN relative_JJ terms_NNS are_VBP not_RB explicit_JJ about_IN the_DT
        time_NN frame_NN involved_VBN and_CC may_MD be_VB erroneously_RB interpreted_VBN as_IN
        accruing_VBG immediately_RB ._. On_IN the_DT other_JJ hand_NN ,_, risks_NNS framed_VBN in_IN
        absolute_JJ terms_NNS or_CC as_IN the_DT NNT_NNP tend_VBP to_TO report_VB a_DT specific_JJ time_NN
        frame_NN and_CC hence_RB may_MD be_VB interpreted_VBN as_IN being_VBG delayed_VBN in_IN
        onset_NN ._. In_IN addition_NN to_TO issues_NNS related_VBN to_TO comprehension_NN ,_,
        patients_NNS may_MD prefer_VB to_TO have_VB risks_NNS presented_VBN over_IN specific_JJ
        time_NN periods_NNS ._.
        While_IN most_JJS framing_VBG studies_NNS focused_VBN on_IN a_DT treatment_NN 's_POS
        effect_NN on_IN a_DT single_JJ outcome_NN over_IN a_DT single_JJ time_NN horizon_NN ,_,
        patients_NNS often_RB need_VBP to_TO decide_VB on_IN treatments_NNS that_WDT affect_VBP
        multiple_JJ outcomes_NNS ,_, both_DT beneficial_JJ and_CC harmful_JJ ._. For_IN
        example_NN ,_, the_DT decision_NN of_IN whether_IN or_CC not_RB to_TO use_VB hormone_NN
        replacement_NN therapy_NN (_( HRT_NNP )_) after_IN menopause_NN involves_VBZ weighing_VBG
        the_DT benefits_NNS of_IN treatment_NN (_( immediate_JJ symptom_NN relief_NN ,_, [_NN 12_CD ]_NN
        decreased_VBD future_JJ risk_NN of_IN hip_NN fracture_NN [_NN 13_CD ]_NN and_CC possible_RB
        decreased_VBD risk_NN of_IN coronary_JJ heart_NN disease_NN [_NN 14_CD 15_CD ]_NN )_)
        against_IN its_PRP$ risks_NNS (_( increased_VBN future_JJ risk_NN of_IN breast_NN cancer_NN [_NN
        15_CD ]_NN )_) ._. Framing_NNP effects_NNS appear_VBP to_TO be_VB smaller_JJR when_WRB both_DT the_DT
        beneficial_JJ and_CC harmful_JJ effects_NNS of_IN a_DT treatment_NN are_NN included_VBN ,_,
        [_NN 16_CD ]_NN but_CC little_JJ information_NN is_VBZ available_JJ to_TO guide_VB
        clinicians_NNS about_IN how_WRB to_TO explain_VB complex_JJ risk_NN information_NN to_TO
        their_PRP$ patients_NNS ._.
        Most_JJS studies_NNS exploring_VBG risk_NN communication_NN and_CC
        decision-making_NN have_VBP focused_VBN on_IN the_DT use_NN of_IN different_JJ
        metrics_NNS ._. However_RB ,_, data_NNS can_MD be_VB described_VBN using_VBG a_DT variety_NN of_IN
        different_JJ graphical_JJ formats_NNS as_RB well_RB ._. Survival_NNP curves_NNS are_VBP
        commonly_RB used_VBN in_IN the_DT scientific_JJ literature_NN and_CC can_MD also_RB be_VB
        used_VBN to_TO help_VB patients_NNS understand_VB risk_NN information_NN when_WRB
        deciding_VBG between_IN two_CD treatments_NNS [_NN 2_CD ]_NN ._. Figures_NNS using_VBG 100_CD
        faces_VBZ or_CC ovals_NNS to_TO represent_VB populations_NNS with_IN and_CC without_IN a_DT
        condition_NN ,_, displayed_VBN in_IN a_DT random_JJ [_NN 17_CD ]_NN or_CC consolidated_JJ [_NN
        18_CD ]_NN fashion_NN ,_, have_VBP gained_VBN increasing_VBG popularity_NN in_IN the_DT lay_VB
        press_NN ,_, as_IN have_VBP simple_JJ bar_NN charts_NNS ._.
        The_DT choice_NN of_IN graphical_JJ formats_NNS may_MD affect_VB patient_NN
        performance_NN on_IN cognitive_JJ tests_NNS ,_, [_NN 19_CD 20_CD 21_CD 22_CD 23_CD ]_NN accuracy_NN
        of_IN comprehension_NN ,_, and_CC speed_NN of_IN processing_NN probabilistic_JJ
        information_NN ._. Vertical_NNP bars_NNS ,_, horizontal_NN bars_NNS ,_, numbers_NNS ,_, and_CC
        100_CD consolidated_JJ ovals_NNS performed_VBD better_JJR than_IN either_DT pie_NN
        charts_NNS or_CC 100_CD random_JJ ovals_NNS when_WRB testing_NN simplified_VBN
        cognitive_JJ tasks_NNS (_( e_SYM ._. g_SYM ._. ,_, identifying_VBG the_DT larger_JJR of_IN two_CD
        quantities_NNS )_) [_NN 24_CD ]_NN ._. The_DT type_NN of_IN visual_JJ graphic_JJ used_VBN to_TO
        present_VB information_NN can_MD also_RB introduce_VB bias_NN in_IN risk_NN
        perception_NN ,_, with_IN risk_NN perceived_VBN to_TO be_VB less_JJR when_WRB using_VBG a_DT bar_NN
        graph_NN versus_CC a_DT stick_NN figure_NN [_NN 25_CD ]_NN ._.
        Numerous_JJ criteria_NNS have_VBP been_VBN used_VBN to_TO evaluate_VB graphical_JJ
        formats_NNS ,_, including_VBG clarity_NN ,_, helpfulness_NNS ,_, [_NN 26_CD 27_CD ]_NN accuracy_NN
        and_CC efficiency_NN ,_, [_NN 24_CD ]_NN though_IN these_DT criteria_NNS may_MD not_RB
        necessarily_RB be_VB those_DT of_IN greatest_JJS importance_NN to_TO patients_NNS
        themselves_PRP ._. Although_IN it_PRP is_VBZ unclear_JJ which_WDT criteria_NNS should_MD be_VB
        used_VBN to_TO evaluate_VB formats_NNS to_TO use_VB with_IN patients_NNS ,_, patient_NN
        preferences_NNS may_MD be_VB an_DT important_JJ consideration_NN ._. Formats_NNP
        preferred_VBN by_IN patients_NNS may_MD reflect_VB higher_JJR perceived_VBN
        relevance_NN ,_, familiarity_NN ,_, usefulness_NN ,_, usability_NN ,_, and_CC
        meaningfulness_NNS ,_, and_CC hence_RB may_MD be_VB more_RBR successful_JJ in_IN
        engaging_VBG their_PRP$ attention_NN ._. The_DT aim_NN of_IN this_DT study_NN is_VBZ to_TO
        determine_VB patient_NN preferences_NNS for_IN the_DT presentation_NN of_IN
        complex_JJ benefit_NN /_NN risk_NN information_NN describing_VBG the_DT impact_NN of_IN
        treatment_NN on_IN multiple_JJ clinical_JJ outcomes_NNS over_IN multiple_JJ time_NN
        horizons_NNS ,_, including_VBG preferences_NNS for_IN graphic_JJ format_NN ,_, time_NN
        horizons_NNS ,_, multiple_JJ outcomes_NNS comparisons_NNS ,_, and_CC metrics_NNS ._. The_DT
        specific_JJ example_NN tested_VBN was_VBD deciding_VBG on_IN HRT_NNP among_IN a_DT
        population_NN of_IN peri-and_JJ postmenopausal_NN women_NNS ._.
      
      
        Methods_NNP
        
          Graphic_NNP format_NN
          We_PRP identified_VBD the_DT following_VBG graphic_JJ formats_NNS as_IN being_VBG
          the_DT most_RBS commonly_RB used_VBN in_IN the_DT scientific_JJ and_CC popular_JJ
          press_NN ,_, and_CC therefore_RB the_DT most_RBS recognizable_JJ to_TO patients_NNS :_:
          bar_NN graphs_NNS ,_, line_NN graphs_NNS ,_, thermometer_NN graphs_NNS ,_, 100_CD
          representative_NN faces_VBZ displayed_VBN in_IN a_DT consolidated_JJ fashion_NN ,_,
          and_CC survival_NN curves_NNS (_( Figures_NNS 1_CD ,_, 2_LS )_) ._. The_DT survival_NN curve_NN
          was_VBD atypical_JJ in_IN that_DT its_PRP$ y-axis_JJ presented_VBD a_DT patient_NN 's_POS
          chance_NN of_IN not_RB developing_VBG a_DT disease_NN instead_RB of_IN the_DT more_RBR
          standard_JJ "_'' chance_NN of_IN survival_NN "_'' ._. This_DT modification_NN was_VBD made_VBN
          to_TO keep_VB the_DT data_NNS presented_VBD consistent_JJ with_IN data_NNS presented_VBN
          in_IN the_DT other_JJ graphical_JJ formats_NNS since_IN survival_NN was_VBD not_RB
          presented_VBN in_IN the_DT other_JJ graphs_NNS (_( the_DT chance_NN of_IN not_RB
          developing_VBG a_DT disease_NN is_VBZ the_DT closest_JJS equivalent_JJ to_TO
          survival_NN ,_, which_WDT is_VBZ the_DT chance_NN of_IN not_RB dying_VBG )_) ._. Pie_NNP charts_NNS
          were_VBD not_RB included_VBN because_IN this_DT format_NN did_VBD not_RB readily_RB
          lend_VB itself_PRP to_TO describing_VBG risks_NNS over_IN time_NN ._. Participants_NNS

          were_VBD sequentially_RB presented_VBN with_IN all_DT graphic_JJ formats_NNS and_CC
          each_DT was_VBD briefly_NN explained_VBD ._. Participants_NNS were_VBD asked_VBN to_TO
          rate_NN how_WRB much_JJ they_PRP liked_VBD each_DT graph_NN on_IN a_DT likert_NN scale_NN of_IN
          1_CD to_TO 5_CD ,_, with_IN 1_CD corresponding_JJ to_TO "_'' not_RB at_IN all_DT "_'' and_CC 5_CD
          corresponding_JJ to_TO "_'' extremely_RB "_'' ,_, and_CC then_RB to_TO rank_VB order_NN the_DT
          graphs_NNS according_VBG to_TO preference_NN ._.
        
        
          Time_NN horizons_NNS
          Participants_NNS were_VBD also_RB asked_VBN to_TO rank_VB order_NN their_PRP$
          preferences_NNS for_IN risk_NN estimates_NNS over_IN 10_CD -_: year_NN ,_, 20_CD -_: year_NN ,_, or_CC
          lifetime_NN horizons_NNS ,_, presented_VBN using_VBG bar_NN graphs_NNS predicting_VBG
          a_DT woman_NN 's_POS risk_NN for_IN developing_VBG heart_NN disease_NN ,_, hip_NN fracture_NN
          and_CC breast_NN cancer_NN ._.
        
        
          Multiple_NNP Outcomes_NNP
          Participants_NNS '_POS preferences_NNS for_IN risk_NN displays_NNS about_IN
          multiple_JJ clinical_JJ outcomes_NNS were_VBD elicited_JJ by_IN asking_VBG
          participants_NNS to_TO choose_VB between_IN 2_CD sets_NNS of_IN 3_CD graphs_NNS ._. In_IN Set_NNP
          A_DT ,_, each_DT of_IN three_CD diseases_NNS was_VBD displayed_VBN separately_RB over_IN 3_CD
          time_NN horizons_NNS (_( Figure_NN 3_LS )_) ._. In_IN Set_NNP B_NNP ,_, the_DT same_JJ three_CD
          diseases_NNS were_VBD displayed_VBN together_RB over_IN one_CD time_NN horizon_NN ;_:
          this_DT was_VBD repeated_VBN for_IN the_DT other_JJ two_CD time_NN horizons_NNS (_( Figure_NN
          4_LS )_) ._. Note_VB that_IN the_DT exact_JJ same_JJ data_NNS were_VBD presented_VBN in_IN each_DT
          set_VBN ,_, differing_VBG only_RB in_IN format_NN ._.
        
        
          Metrics_NNP
          Preferences_NNPS for_IN absolute_JJ vs_NNS ._. relative_JJ risk_NN estimates_NNS
          were_VBD obtained_VBN by_IN asking_VBG participants_NNS to_TO choose_VB between_IN
          risk_NN estimates_NNS for_IN heart_NN disease_NN framed_VBN in_IN either_DT
          absolute_JJ or_CC relative_JJ terms_NNS ,_, both_DT graphically_RB and_CC
          textually_RB ._. Finally_RB ,_, participants_NNS evaluated_VBD the_DT concept_NN of_IN
          NNT_NNP presented_VBD with_IN two_CD written_VBN explanations_NNS ._. The_DT first_JJ
          explanation_NN (_( referred_VBD to_TO as_IN "_'' 1_CD in_IN x_SYM "_'' )_) was_VBD worded_VBN "_'' If_IN 8_CD
          women_NNS just_RB like_IN you_PRP took_VBD lifelong_JJ HRT_NNP ,_, it_PRP would_MD prevent_VB
          one_CD of_IN the_DT 8_CD from_IN having_VBG heart_NN disease_NN ._. If_IN 9_CD women_NNS took_VBD
          lifelong_JJ HRT_NNP ,_, it_PRP would_MD prevent_VB one_CD of_IN the_DT 9_CD from_IN having_VBG a_DT
          hip_NN fracture_NN ._. If_IN 17_CD women_NNS took_VBD lifelong_JJ HRT_NNP ,_, it_PRP would_MD
          cause_VB one_CD of_IN the_DT 17_CD to_TO develop_VB breast_NN cancer_NN ._. There_EX is_VBZ no_DT
          way_NN of_IN knowing_VBG in_IN advance_NN who_WP these_DT women_NNS might_MD be_VB ._. "_'' The_DT
          alternative_JJ explanation_NN (_( referred_VBD to_TO as_IN "_'' x_SYM out_IN of_IN 100_CD "_'' )_)
          was_VBD worded_VBN "_'' If_IN 100_CD women_NNS just_RB like_IN you_PRP were_VBD to_TO take_VB
          lifelong_JJ HRT_NNP ,_, treatment_NN would_MD prevent_VB 12_CD of_IN them_PRP from_IN
          developing_VBG heart_NN disease_NN and_CC 11_CD of_IN them_PRP from_IN developing_VBG a_DT
          hip_NN fracture_NN ._. However_RB ,_, treatment_NN would_MD cause_VB 6_CD of_IN them_PRP to_TO
          develop_VB breast_NN cancer_NN ._. There_EX is_VBZ no_DT way_NN of_IN knowing_VBG in_IN
          advance_NN who_WP these_DT women_NNS might_MD be_VB ._. "_''
          We_PRP assessed_VBD differences_NNS in_IN patients_NNS '_POS preferences_NNS
          between_IN the_DT two_CD graphs_NNS with_IN the_DT highest_JJS mean_NN rating_NN using_VBG
          a_DT Wilcoxon_NNP signed-rank_JJ test_NN ._. Descriptive_NNP statistics_NNS were_VBD
          performed_VBN on_IN subgroups_NNS stratified_JJ according_VBG to_TO race_NN
          (_( Caucasian_NNP vs_NNS ._. non-_NN Caucasian_NNP )_) ,_, annual_JJ household_NN income_NN
          (_( <_NN $_$ 50_CD ,_, 000_CD vs_NNS ._. ≥_NN $_$ 50_CD ,_, 000_CD )_) ,_, and_CC education_NN (_( <_NN 2_CD years_NNS
          college_NN vs_NNS ._. ≥_NN 2_CD years_NNS college_NN )_) ._. Statistical_NNP comparisons_NNS
          within_IN subgroups_NNS were_VBD not_RB performed_VBN due_JJ to_TO the_DT small_JJ
          sample_NN size_NN ._.
        
      
      
        Results_NNS
        Study_NN participants_NNS included_VBD a_DT diverse_JJ group_NN of_IN 40_CD peri-_NN
        and_CC post-menopausal_JJ women_NNS (_( Table_NNP 1_LS )_) ._. Half_NN of_IN our_PRP$ sample_NN
        identified_VBD themselves_PRP as_IN non-_NN Caucasian_NNP ._. All_DT participants_NNS
        had_VBD at_IN least_JJS some_DT high_JJ school_NN education_NN ;_: most_JJS (_( 60_CD %_NN )_) had_VBD an_DT
        annual_JJ household_NN income_NN of_IN less_JJR than_IN $_$ 50_CD ,_, 000_CD ._.
        The_DT mean_JJ preference_NN rating_NN for_IN the_DT bar_NN graph_NN exceeded_VBD
        those_DT of_IN the_DT four_CD other_JJ graphs_NNS in_IN this_DT set_JJ (_( Table_NNP 2_LS )_) ._. Most_JJS
        respondents_NNS (_( 83_CD %_NN )_) ranked_VBD the_DT bar_NN graph_NN as_IN being_VBG their_PRP$ first_JJ
        or_CC second_JJ most_RBS preferred_VBN graph_NN ,_, with_IN more_JJR than_IN half_NN of_IN all_DT
        respondents_NNS (_( 60_CD %_NN )_) selecting_VBG the_DT bar_NN graph_NN as_IN their_PRP$ first_JJ
        choice_NN (_( Figure_NN 5_LS )_) ._. The_DT bar_NN graph_NN was_VBD consistently_RB rated_VBN
        highest_JJS when_WRB the_DT sample_NN population_NN was_VBD stratified_JJ according_VBG
        to_TO race_NN ,_, income_NN and_CC educational_JJ status_NN ._. Sub-group_NNP analyses_NNS
        are_VBP shown_VBN in_IN Table_NNP 2_CD ,_, recognizing_VBG that_IN these_DT analyses_NNS are_VBP
        limited_JJ considering_VBG the_DT small_JJ sample_NN size_NN ._.
        Most_JJS respondents_NNS preferred_VBN receiving_NN risk_NN estimates_NNS over_IN
        multiple_JJ time_NN horizons_NNS vs_NNS ._. at_IN one_CD time_NN point_NN ._. When_WRB asked_VBD to_TO
        prioritize_NN ,_, a_DT majority_NN preferred_VBN receiving_NN lifetime_NN risk_NN
        estimates_NNS instead_RB of_IN 10_CD or_CC 20_CD -_: year_NN time_NN horizons_NNS (_( Table_NNP
        3_CD a_DT )_) ._. There_EX was_VBD no_DT clear_JJ preference_NN for_IN the_DT type_NN of_IN
        presentation_NN comparing_VBG risks_NNS for_IN multiple_JJ disease_NN outcomes_NNS
        over_IN different_JJ time_NN horizons_NNS (_( Table_NNP 3_CD b_SYM )_) ._. Respondents_NNP
        preferred_VBN risk_NN estimates_NNS framed_VBN in_IN absolute_JJ rather_RB than_IN
        relative_JJ terms_NNS for_IN both_DT graphical_JJ and_CC textual_NN displays_NNS
        (_( Table_NNP 3_CD c_SYM )_) ;_: this_DT finding_VBG was_VBD consistent_JJ across_IN racial_JJ ,_,
        income_NN ,_, and_CC educational_JJ sub-groups_JJ ._. Participants_NNS
        consistently_RB stated_VBN that_IN they_PRP wanted_VBD graphical_JJ and_CC textual_NN
        explanations_NNS of_IN absolute_JJ risks_NNS provided_VBN together_RB ._. In_IN
        describing_VBG NNT_NNP ,_, respondents_NNS preferred_VBN the_DT written_VBN
        explanation_NN which_WDT rescaled_JJ data_NNS from_IN "_'' 1_CD -_: in_IN x_SYM "_'' to_TO "_'' x_SYM out_IN of_IN
        100_CD "_'' (_( Table_NNP 3_CD d_SYM )_) ._.
      
      
        Discussion_NNP
        
          Limitations_NNPS
          The_DT present_JJ study_NN included_VBD a_DT small_JJ ,_, self-selected_JJ
          population_NN of_IN women_NNS who_WP were_VBD more_RBR likely_JJ to_TO be_VB interested_JJ
          in_IN health-related_JJ activities_NNS ._. Our_PRP$ sample_NN size_NN was_VBD small_JJ
          because_IN focus_NN groups_NNS and_CC 1_CD -_: on-_NN 1_CD interviews_NNS were_VBD
          originally_RB conducted_VBN to_TO discuss_VB HRT_NNP and_CC decision-making_NN
          issues_NNS ._. When_WRB convergence_NN was_VBD reached_VBN on_IN these_DT broader_JJR
          topics_NNS ,_, we_PRP ceased_VBD recruitment_NN and_CC analyzed_VBD data_NNS from_IN
          these_DT respondents_NNS ._. While_IN these_DT results_NNS may_MD not_RB be_VB
          generalizable_JJ to_TO all_DT women_NNS ,_, our_PRP$ sample_NN included_VBD a_DT diverse_JJ
          group_NN of_IN women_NNS with_IN respect_NN to_TO race_NN ,_, income_NN ,_, and_CC
          educational_JJ background_NN ._. Recognizing_NNP that_WDT focus_VBP group_NN
          discussions_NNS might_MD lead_VB to_TO "_'' group_NN think_VBP "_'' ,_, we_PRP control_VBP for_IN
          this_DT by_IN asking_VBG participants_NNS to_TO privately_RB write_VB down_RP their_PRP$
          personal_JJ preferences_NNS before_IN they_PRP were_VBD discussed_VBN ._.
          A_DT formal_JJ analysis_NN of_IN patient_NN comprehension_NN for_IN each_DT
          presentation_NN format_NN was_VBD beyond_IN the_DT scope_NN of_IN the_DT present_JJ
          study_NN ;_: however_RB data_NNS on_IN this_DT topic_NN has_VBZ been_VBN previously_RB
          reported_VBN [_NN 24_CD ]_NN ._. While_IN responses_NNS from_IN focus_NN group_NN
          participants_NNS reflected_VBD how_WRB well_RB they_PRP felt_VBD they_PRP could_MD
          understand_VB the_DT information_NN in_IN various_JJ formats_NNS ,_, no_DT formal_JJ
          testing_NN of_IN comprehension_NN was_VBD performed_VBN ._. Analyzing_NNP
          comprehension_NN of_IN each_DT format_NN at_IN this_DT stage_NN was_VBD not_RB
          feasible_JJ considering_VBG the_DT additional_JJ time_NN burden_NN it_PRP would_MD
          have_VB imposed_VBN on_IN our_PRP$ study_NN participants_NNS (_( focus_VB group_NN
          sessions_NNS lasted_VBD a_DT full_JJ 2_CD hours_NNS )_) ._. Presentation_NNP formats_NNS
          that_WDT are_VBP not_RB understandable_JJ may_MD be_VB misinterpreted_VBN ;_:
          formats_NNS that_WDT are_VBP unappealing_JJ may_MD be_VB ignored_VBN ._. Therefore_RB ,_,
          future_JJ studies_NNS might_MD test_VB both_DT comprehension_NN and_CC patient_NN
          preferences_NNS simultaneously_RB to_TO develop_VB future_JJ risk_NN
          communication_NN tools_NNS ._.
          The_DT graphical_JJ presentations_NNS utilized_JJ were_VBD hypothetical_JJ
          in_IN that_IN they_PRP did_VBD not_RB present_VB each_DT individual_NN 's_POS personal_JJ
          risk_NN estimates_NNS ,_, but_CC those_DT of_IN a_DT theoretical_JJ woman_NN ._. It_PRP is_VBZ
          unlikely_JJ that_IN patients_NNS '_POS preferences_NNS for_IN risk_NN estimate_NN
          presentations_NNS would_MD have_VB been_VBN different_JJ had_VBN they_PRP been_VBN
          shown_VBN their_PRP$ own_JJ risk_NN estimates_NNS ._. Not_RB all_DT possible_JJ graph_NN
          types_NNS were_VBD presented_VBN to_TO study_VB participants_NNS ,_, although_IN we_PRP
          attempted_VBD to_TO include_VB the_DT most_RBS common_JJ graph_NN types_NNS from_IN the_DT
          scientific_JJ and_CC popular_JJ press_NN ._. Although_IN we_PRP did_VBD not_RB
          systematically_RB study_VB the_DT reasons_NNS for_IN participants_NNS '_POS stated_VBN
          preferences_NNS ,_, participants_NNS were_VBD asked_VBN open-ended_JJ questions_NNS
          to_TO understand_VB these_DT preferences_NNS ._. Finally_RB ,_, since_IN
          scientific_JJ literature_NN traditionally_RB presents_VBZ 5_CD -_: year_NN
          survival_NN data_NNS ,_, it_PRP might_MD be_VB difficult_JJ to_TO compare_VB our_PRP$ data_NNS ,_,
          based_VBN on_IN 10_CD -_: year_NN ,_, 20_CD -_: year_NN and_CC lifetime_NN horizons_NNS ,_, to_TO that_DT
          in_IN the_DT current_JJ literature_NN ._.
        
      
      
        Conclusions_NNP
        Patients_NNS preferred_VBN health_NN risks_NNS to_TO be_VB framed_VBN in_IN absolute_JJ
        terms_NNS ,_, using_VBG bar_NN graphs_NNS ,_, and_CC calculated_VBD over_IN their_PRP$ expected_VBN
        lifetime_NN ._. There_EX was_VBD no_DT clear_JJ preference_NN for_IN presenting_VBG a_DT
        treatment_NN 's_POS effect_NN on_IN multiple_JJ outcomes_NNS ._. The_DT NNT_NNP is_VBZ not_RB an_DT
        easily_RB understood_VBN concept_NN for_IN patients_NNS ,_, but_CC if_IN used_VBN to_TO
        discuss_VB multiple_JJ outcomes_NNS ,_, it_PRP should_MD be_VB re-scaled_JJ to_TO "_'' x_SYM out_IN
        of_IN 100_CD "_'' ._. The_DT results_NNS of_IN these_DT analyses_NNS should_MD help_VB
        physicians_NNS present_JJ risk_NN /_NN benefit_NN information_NN to_TO patients_NNS in_IN
        a_DT clear_JJ and_CC useful_JJ manner_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN ._.
      
    
  
